Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein

Cell Growth and Differentiation

Volumn 7, Issue 5, 1996, Pages 629-634

  Lotsova, Violette ^a,b   Stehelin, Dominique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; FIBRONECTIN; INTEGRIN; MESSENGER RNA; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTISENSE ELEMENTS (GENETICS); BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, FIBRONECTIN; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029826240     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Martinez, J., Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes & Dev., 5: 151-159, 1991.
2. EI-Deiry, W. S., Tokino, T., Velculesco, V., Levy, D. B., Parsons, R., Trenl, J. M., Lin, D., Mercer, E. W., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
3. Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA, 88: 9979-9983, 1991.
4. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C. Wild-type p53 activates transcription in vitro. Nature (Lond.), 358: 83-86, 1992.
5. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12: 2866-2871, 1992.
6. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
7. Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., and Levine, A. J. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes & Dev., 6: 1143-1152, 1992.
8. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.
9. Weintraub, H., Hauschka, S., and Tapscott, S. J. The MCK enhancer contains a p53 responsive element. Proc. Natl. Acad. Sc. USA, 88: 4570-4571, 1991.
10. Kastan, M. B., Zhan, K., EI-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell-cycle checkpoint utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
11. Barak, Y., Juven, T., Hatfner, R., and Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J., 12: 461-468, 1993.
12. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayaski, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
13. Harper, J. W., Adami, G. R., Wei, N., Keyormarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
14. Santhanam, U., Ray, A., and Sehgal, P. B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA, 68: 7605-7609, 1991.
15. Subler, M. A., Martin, D. W., and Deb, S. Inhibition of viral and cellular promoters by human wild-type p53. J. Virol., 66: 4757-4762, 1992.
16. lotsova, V., and Stehelin, D. Antisense p53 provokes changes in HeLa cell growth and morphology. Eur. J. Cell Biol., 68: 122-132, 1995.
17. Hoppe-Seyler, F., and Butz, K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol., 67: 3111-3117, 1993.
18. Hynes, R. O. Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc. Natl. Acad. Sci. USA, 70: 3170-3174, 1973.
19. Chen, W-T., Hasegawa, E., Hasegawa, T., Weinstock, C., and Yamada, K. M. Development of cell surface linkage complexes in cultured fibroblasts. J. Cell Biol., 100: 1103-1114, 1985.
20. Dean, D. C., Newby, R. F., and Bourgeois, S. Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor β, and cAMP in human cell lines. J. Cell Biol., 106: 2159-2170, 1988.
21. Ruoslahti, E. Fibronectin and its receptors. Annu. Rev. Biochem., 57: 375-413, 1988.
22. Liotta, L. A. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res., 46: 1-7, 1986.
23. Dean, D. C., Blakely, M. S., Newby, R. F., Ghazal, P., Henninghauser, L., and Bourgeois, S. Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol. Cell. Biol., 9: 1498-1506, 1989.
24. Bernath, V. A., Muro, A. F., Vitullo, A. D., Bley, M. A., Baranao, J. L., and Kornblihtt, A. R. Cyclic AMP inhibits fibronectin gene expression in a newly developed granuloma cell line by a mechanism that suppresses cAMP-responsive element-dependent transcriptional activation. J. Biol. Chem., 265: 18219-18226, 1990.
25. Muro, A. F., Bernath, V. A., and Kornblihtt, A. R. Interaction of the -170 cyclic AMP response element with the adjacent CCAAT box in the human fibronectin gene promoter. J. Biol. Chem., 267: 12767-12774, 1992.
26. Agoff, S. N., Hou, J., Linzer, D. I. H., and Wu, B. Regulation of the human hsp70 promoter by p53. Science (Washington DC), 259: 84-87, 1993.
27. Hynes, R. O. Molecular biology of fibronectin. Annu. Rev. Cell Biol., 1: 67-90, 1985.
28. Kornblihtt, A. R., and Gutman, A. Molecular biology of the extracellular matrix proteins. Biol. Rev. Camb. Philos. Soc., 63: 465-507, 1988.
29. Ruoslahti, E., Suzuki, S., Hyman, E. G., Ill, C. R., and Pierschbacher, M. D. Purification and characterization of vitronectin. Methods Enzymol., 144: 430-437, 1987.
30. Martin, G. R. Laminin and other basement membrane components. Annu. Rev. Cell Biol., 3: 57-85, 1987.
31. Yamada, K. M., Yamada, S. S., and Pastan, I. Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proc. Natl. Acad. Sci. USA, 73: 1217-1221, 1976.
32. Lacovara, J., Cramer, E. B., and Quigley, J. P. Fibronectin enhancement of directed migration of B16 melanoma cells. Cancer Res., 44: 1657-1663, 1984.
33. Hynes, R. O., and Lander, A. D. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell, 68: 303-322, 1992.
34. 1/S control of anchorage-independent growth in the fibroblast cell cycle. J. Cell Biol., 115: 1419-1425, 1991.
35. Benecke, B-J., Ben-Ze'ev, A., and Penman, S. The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts. Cell, 14: 931-939, 1978.
36. Cross, F., Roberts, H., and Weintraub, H. Simple and complex cell cycles. Annu. Rev. Cell Biol., 5: 341-396, 1989.
37. 1 events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989.
38. 1 phase. Proc. Natl. Acad. Sci. USA, 89: 9210-9214, 1992.
39. 1 arrest. Cell, 76: 1013-1023, 1994.
40. Guadagno, T. M., Ohtsubo, M., Roberts, J. M., and Assoian, R. K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (Washington DC), 262: 1572-1575, 1993.
41. Ryseck, R-P., MacDonald-Bravo, H., Zerial, M., and Bravo, R. Coordinate induction of fibronectin, fibronectin receptor, tropomyosin, and actin genes in serum-stimulated fibroblasts. Exp. Cell Res., 180: 537-545, 1989.
42. Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Washington DC), 262: 1731-1734, 1993.
43. Su, L. K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1734-1737, 1993.
44. Suzuki, M., Kuroda, C., Oda, E., Tsunoda, S., Nakamura, T., Nakajima, T., and Oda, K. G10BP, an E1A-inducible negative regulator of Sp1, represses transcription of the rat fibronectin gene. Mol. Cell. Biol., 15: 5423-5433, 1995.
45. Dry, K., Legros, Y., Auguin, C., and Soussi, T. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with the loss of transactivation or inhibition of cell proliferation. EMBO J., 13: 3496-3504, 1994.
46. Gorman, C. In: D. M. Glover (ed.), DNACloning. A Practical Approach, Vol. II, pp. 143-190. Oxford, United Kingdom: IRL Press, 1985.
47. Obara, M., Kang, M. S., Dufour, S., Kornblihtt, A. R., Thiéry, J. P., and Yamada, K. M. Expression of the cell-binding domain of human fibronectin in E. Coli. FEBS Lett., 213: 261-264, 1987.